DYN PEER ANALYSIS

Dyne Therapeutics Inc — metric-by-metric comparison with peers and the industry median

DYNDyne Therapeutics Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value it Duel

Overall Profile & Returns

· Biotechnology

Position Within Industry

0 = weak quartile, 100 = strong quartile

DYNIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year

Split-adjusted

Year-to-Date (YTD)

Key Metric Comparison

P/E

Lower is better

ROE

Higher is better

Net Margin

Higher is better

Revenue Growth

Higher is better

All Metrics

Valuation
Metric	DYN	TLX	MSB	CSL	Ind. Median
P/E	—	—	—	30.02	17.81
P/B	4.36	6.56	—	2.24●	3.49
EV/EBITDA	—	123.31	—	10.37●	14.92
P/S	—	3.34	31.91	2.67●	10.89

Financial Health
Metric	DYN	TLX	MSB	CSL	Ind. Median
Current Ratio	19.92●	1.43	—	2.57	5.90
Debt/Equity	2.2%●	112.3%	—	67.4%	10.9%
NetDebt/EBITDA	2.20●	13.13	—	2.22	1.15

Profitability
Metric	DYN	TLX	MSB	CSL	Ind. Median
Net Margin	—	-0.9%	-115.3%	9.2%●	-125.7%
ROE	-58.9%	-1.8%	-11.3%	7.7%●	-47.5%
ROA	-50.2%	-0.7%	-8.6%	3.8%●	-35.8%
EBITDA Margin	—	3.0%	-76.6%	32.8%●	-105.8%

Growth + Dividend
Metric	DYN	TLX	MSB	CSL	Ind. Median
Rev. Growth	-100.0%	56.3%	410.4%●	4.8%	5.1%
NI Growth	—	—	—	-39.4%	12.1%
Div. Yield	—	—	0.0%	2.5%●	0.2%
Payout	—	—	0.0%	103.1%	0.0%

Valuation
Metric	DYN	RCUS	CPRX	BEAM	TNGX	EWTX	Ind. Median
P/E	—	—	18.06	—	—	—	17.81
P/B	4.36	7.17	3.95	3.13●	10.98	8.71	3.49
EV/EBITDA	—	—	9.69	—	—	—	14.92
P/S	—	15.93	6.70●	22.24	75.43	—	10.89

Financial Health
Metric	DYN	RCUS	CPRX	BEAM	TNGX	EWTX	Ind. Median
Current Ratio	19.92	4.04	7.10	16.99	27.38●	22.61	5.90
Debt/Equity	2.2%	21.6%	0.3%●	21.5%	8.4%	0.8%	10.9%
NetDebt/EBITDA	2.20	2.15	-2.25●	30.00	3.30	2.82	1.15

Profitability
Metric	DYN	RCUS	CPRX	BEAM	TNGX	EWTX	Ind. Median
Net Margin	—	-156.4%	37.1%●	-39.7%	-188.2%	—	-125.7%
ROE	-58.9%	-70.0%	24.5%●	-5.7%	-38.4%	-38.1%	-47.5%
ROA	-50.2%	-34.3%	21.5%●	-4.4%	-30.2%	-36.2%	-35.8%
EBITDA Margin	—	-139.8%	56.1%●	-19.5%	-184.5%	—	-105.8%

Growth + Dividend
Metric	DYN	RCUS	CPRX	BEAM	TNGX	EWTX	Ind. Median
Rev. Growth	-100.0%	67.4%	11.7%	158.0%●	39.0%	-100.0%	5.1%
NI Growth	—	—	12.1%	—	—	—	12.1%
Div. Yield	—	—	—	—	—	—	0.2%
Payout	—	—	—	—	—	—	0.0%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on DYN

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 6, 26. This content is for informational purposes only and is not investment advice.